Pfizer: all 4,072 studies
Page 9 of 41. Open to participants first (153), then studies with results posted, then the rest; newest registration first within each.
- A Study of Vadastuximab Talirine Given Prior to or After Allogeneic Hematopoietic Stem Cell Transplant in AML PatientsTerminatedNCT02614560Phase 1/2Results posted
- Phase 3 Study on the Efficacy and Safety of Tanezumab in Patients With Cancer Pain Due to Bone Metastasis Who Are Taking Background Opioid TherapyCompletedNCT02609828Phase 3Results posted
- Post-Marketing Use Of CT-P13 (Infliximab) For Standard Of Care Treatment Of Rheumatoid Diseases Who Are Naïve To Biologics Or Switched From RemicadeCompletedNCT02605642Results posted
- A Study Of Avelumab In Patients With Locally Advanced Or Metastatic Urothelial Cancer (JAVELIN Bladder 100)CompletedNCT02603432Phase 3Results posted
- Avelumab In Patients With Previously Treated Advanced Stage Classical Hodgkin's Lymphoma (JAVELIN HODGKINS)TerminatedNCT02603419Phase 1Results posted
- Palbociclib Plus Letrozole For Postmenopausal Women With HR(+) HER2(-) Advanced Breast Cancer For Whom Letrozole Is Deemed AppropriateCompletedNCT02600923Phase 3Results posted
- Study of Rituximab and Bendamustine With or Without Brentuximab Vedotin for CD30 Positive Diffuse Large B-cell LymphomaTerminatedNCT02594163Phase 2Results posted
- Treatment Study of Denintuzumab Mafodotin (SGN-CD19A) Plus RICE Versus RICE Alone for Diffuse Large B-Cell LymphomaTerminatedNCT02592876Phase 2Results posted
- Efficacy Study Of Tofacitinib In Pediatric JIA PopulationCompletedNCT02592434Phase 3Results posted
- Study to Evaluate Safety, Efficacy, Pharmacokinetics And Pharmacodynamics Of Avelumab In Combination With Either Crizotinib Or PF-06463922 In Patients With NSCLC. (Javelin Lung 101)TerminatedNCT02584634Phase 1/2Results posted
- A Study Of Avelumab Alone Or In Combination With Pegylated Liposomal Doxorubicin Versus Pegylated Liposomal Doxorubicin Alone In Patients With Platinum Resistant/Refractory Ovarian Cancer (JAVELIN Ovarian 200)CompletedNCT02580058Phase 3Results posted
- A Dose Escalation Study Of PF-06801591 In Melanoma, Head And Neck Cancer (SCCHN), Ovarian, Sarcoma, Non-Small Cell Lung Cancer, Urothelial Carcinoma or Other Solid TumorsCompletedNCT02573259Phase 1Results posted
- A Study of Brentuximab Vedotin Combined With Nivolumab for Relapsed or Refractory Hodgkin LymphomaCompletedNCT02572167Phase 1/2Results posted
- The Effect Of Smoking Status Of The Patient On The Success Of Etanercept Therapy In PsoriasisCompletedNCT02570750Results posted
- PF-06669571 In Subjects With Idiopathic Parkinson's DiseaseCompletedNCT02565628Phase 1Results posted
- PF-06372865 in Subjects With Photosensitive EpilepsyCompletedNCT02564029Phase 2Results posted
- A Study To Investigate Two 3-dose Schedules Of A Clostridium Difficile Vaccine In Healthy Adults Aged 65 to 85 YearsCompletedNCT02561195Phase 2Results posted
- A 12-week Study To Evaluate PF-06291874 Once a Day in Adults With T2DM Inadequately Controlled On MetforminCompletedNCT02554877Phase 2Results posted
- A Study Of Avelumab In Combination With Other Cancer Immunotherapies In Advanced Malignancies (JAVELIN Medley)TerminatedNCT02554812Phase 1/2Results posted
- Vfend Special Investigation For Pediatric - ObservationalCompletedNCT02554656Results posted
- Tisotumab Vedotin (HuMax®-TF-ADC) Safety Study in Patients With Solid TumorsCompletedNCT02552121Phase 1/2Results posted
- Korean Post Marketing Surveillance to Observe Effectiveness and Safety of PRISTIQCompletedNCT02548949Results posted
- A Study To Describe The Real World Use Of Bosutinib In The UK And NetherlandsCompletedNCT02546375Results posted
- Post-Marketing Use Of CT-P13 (Infliximab) For Standard Of Care Treatment Of Inflammatory Bowel DiseaseCompletedNCT02539368Results posted
- Extension Study of APD334-003 in Patients With Moderately to Severely Active Ulcerative ColitisCompletedNCT02536404Phase 2Results posted
- Immunogenicity, Safety and Tolerability of a Neisseria Meningitidis Serogroup B Bivalent Recominant Lipoprotein 2086 Vaccine (Bivalent rLP2086) in Healthy Toddlers.CompletedNCT02534935Phase 2Results posted
- Dose Ranging Study of Brentuximab Vedotin in Adults With LupusTerminatedNCT02533570Phase 2Results posted
- Post-Marketing Surveillance Study To Observe INLYTA® Treatment Dosing Pattern, Safety And Effectiveness In Taiwan Real World Routine PracticeCompletedNCT02533258Results posted
- A Study to Describe the Immunogenicity, Safety, and Tolerability of Neisseria Meningitidis Serogroup B Bivalent Recombinant Lipoprotein 2086 Vaccine (Bivalent rLP2086) in Healthy Subjects Aged ≥24 Months to <10 YearsCompletedNCT02531698Phase 2Results posted
- A Phase 3 Study of Tanezumab for Chronic Low Back PainCompletedNCT02528253Phase 3Results posted
- Long Term Safety and Efficacy Study of Tanezumab in Subjects With Osteoarthritis of the Hip or KneeCompletedNCT02528188Phase 3Results posted
- Crizotinib Plus Pembrolizumab In Alk-Positive Advanced Non Small Cell Lung Cancer PatientsTerminatedNCT02511184Phase 1Results posted
- First-In-Human Study Of Single And Multiple Ascending Doses Of PF-06751979CompletedNCT02509117Phase 1Results posted
- Etanercept Withdrawal And Retreament Study In Subjects With Nr-ax SpACompletedNCT02509026Phase 4Results posted
- A Phase 3b Study of Erythropoietin Drugs Using a Specified Dosing Algorithm in Patients With Chronic Kidney Disease on HemodialysisCompletedNCT02504294Phase 3Results posted
- Open-label Long-term Extension Study of Fesoterodine in Japanese Subjects With Neurogenic Detrusor Overactivity.CompletedNCT02501928Phase 3Results posted
- Dose-Escalation Study Of Palbociclib + Nab-Paclitaxel In mPDACCompletedNCT02501902Phase 1Results posted
- Palbociclib Pharmacokinetics Study In Postmenopausal Chinese Women With ER (+), HER2 (-) Advanced Breast CancerCompletedNCT02499146Phase 1Results posted
- Safety And Efficacy Study Of Palbociclib Plus Cetuximab Versus Cetuximab To Treat Head And Neck CancerCompletedNCT02499120Phase 2Results posted
- Evaluation of Safety, Pharmacokinetics and Efficacy of Ceftazidime and Avibactam (CAZ-AVI ) Compared With Cefepime in Children From 3 Months to Less Than 18 Years of Age With Complicated Urinary Tract Infections (cUTIs)CompletedNCT02497781Phase 2Results posted
- A Study Of Avelumab In Combination With Axitinib In Advanced Renal Cell Cancer (JAVELIN Renal 100)CompletedNCT02493751Phase 1Results posted
- PF-05208756, Moroctocog Alfa (AF-CC), Xyntha For Hemophilia ACompletedNCT02492984Phase 4Results posted
- SA4Ag Safety, Tolerability, and Immunogenicity Study in Japanese AdultsCompletedNCT02492958Phase 2Results posted
- A Study To Evaluate The Efficacy Of Enbrel (REGISTERED) Etanercept Over A Period Of 12 Months In The Routine Treatment Of Patients With Rheumatoid Arthritis, Axial Spondyloarthritis, Psoriatic Arthritis, Or Plaque Psoriasis.CompletedNCT02486302Results posted
- A Gene Therapy Study for Hemophilia BCompletedNCT02484092Phase 2Results posted
- A Study Of PF-06410293 (Adalimumab-Pfizer) And Adalimumab (Humira®) In Combination With Methotrexate In Subjects With Active Rheumatoid Arthritis (REFLECTIONS B538-02).CompletedNCT02480153Phase 3Results posted
- Evaluation of Safety,Pharmacokinetics and Efficacy of CAZ-AVI With Metronidazole in Children Aged 3 Months to 18 Years Old With Complicated Intra-abdominal Infections (cIAIs).CompletedNCT02475733Phase 2Results posted
- Study of PF-05208756, Moroctocog Alfa (AF-CC), Xyntha For Male Chinese Subjects With Hemophilia ACompletedNCT02461992Phase 1Results posted
- Efficacy, Safety, Tolerability And Actual Use Study Of Bococizumab And An Autoinjector (Pre-Filled Pen) In Subjects With Hyperlipidemia Or DyslipidemiaCompletedNCT02458287Phase 3Results posted
- Use of Biosimilar Nivestim® to Prevent Chemo-induced Neutropenia. Real Life StudyTerminatedNCT02454530Results posted
- Safety and Efficacy of Etrasimod (APD334) in Patients With Ulcerative ColitisCompletedNCT02447302Phase 2Results posted
- A Study of PF-05082566 In Combination With Mogamulizumab In Patients With Advanced Solid TumorsTerminatedNCT02444793Phase 1Results posted
- Safety, Tolerability and Efficacy of Ceftaroline in Paediatrics With Late-Onset SepsisTerminatedNCT02424734Phase 2Results posted
- A Study To Examine Safety, Pharmacokinetics, And Pharmacodynamic Of Pf 06412562 In Subjects With SchizophreniaCompletedNCT02418819Phase 1Results posted
- PREA, PK And Safety PASS Study Of IV Pantoprazole In Pediatric SubjectsTerminatedNCT02401035Phase 4Results posted
- Safety and Efficacy of SA4Ag Vaccine in Adults Having Elective Open Posterior Spinal Fusion Procedures With Multilevel InstrumentationTerminatedNCT02388165Phase 2Results posted
- A Positron Emission Tomography/Computed Tomography (PET/CT) Bone Imaging Study in Patients Receiving Enzalutamide for Castration-Resistant Prostate Cancer (CRPC)CompletedNCT02384382Phase 2Results posted
- A Rollover Protocol of Dacomitinib For Patients In JapanCompletedNCT02382796Phase 2Results posted
- Study to Assess the Immunogenicity, Safety, and Efficacy of High Capacity Process Etanercept in Rheumatoid Arthritis SubjectsCompletedNCT02378506Phase 3Results posted
- A Combination Study of PF-04449913 (Glasdegib) and Azacitidine In Untreated MDS, AML and CMML PatientsCompletedNCT02367456Phase 1Results posted
- An Evaluation Of PF-03715455 In Moderate To Severe Chronic Obstructive Pulmonary DiseaseTerminatedNCT02366637Phase 2Results posted
- A Comparative Study Of PF-06439535 Plus Paclitaxel-Carboplatin And Bevacizumab Plus Paclitaxel-Carboplatin Patients With Advanced Non-Squamous NSCLCCompletedNCT02364999Phase 3Results posted
- A Rollover Study of ARRY-371797 in Patients With LMNA-Related Dilated CardiomyopathyCompletedNCT02351856Phase 2Results posted
- Study For Patients With NSCLC EGFR Mutations (Del 19 or L858R +/- T790M)TerminatedNCT02349633Phase 1/2Results posted
- Open Label Extension Study To Investigate Long Term Safety, Tolerability And Efficacy Of Pf-02545920 In Subjects With Huntington's Disease Who Completed Study A8241021TerminatedNCT02342548Phase 2Results posted
- Safety and Efficacy of Benefix in Patients With Hemophilia B in Usual Care Settings in ChinaCompletedNCT02336178Phase 4Results posted
- A Study To Describe The Effect Of Impaired Hepatic Function Of The Pharmacokinetics Of PalbociclibCompletedNCT02334800Phase 1Results posted
- Safety and Efficacy Study of Enzalutamide Plus Leuprolide in Patients With Nonmetastatic Prostate Cancer (EMBARK)Active, not recruitingNCT02319837Phase 3Results posted
- A Study to Estimate the Effect of CYP3A4 Inhibitors (Itraconazole, Diltiazem or Verapamil) on the Pharmacokinetics of Single Dose PF- 00489791 in Healthy VolunteersCompletedNCT02319148Phase 1Results posted
- Observational Study Evaluating The Efficacy And Effects On Quality Of Life Of Targeted Treatments Following TKIs In mRCCCompletedNCT02315755Results posted
- Study Of OX40 Agonist PF-04518600 Alone And In Combination With 4-1BB Agonist PF-05082566CompletedNCT02315066Phase 1Results posted
- A Phase 2 Study to Evaluate the Safety, Efficacy, Pharmacokinetics and Pharmacodynamics of PF-06252616 in Duchenne Muscular DystrophyTerminatedNCT02310763Phase 2Results posted
- A Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Study Of PF-06700841, With Bioavailability/Food Effect InvestigationCompletedNCT02310750Phase 1Results posted
- POC Study in Partially Responsive Generalized Anxiety DisorderTerminatedNCT02310568Phase 2Results posted
- Retrospective Epidemiology Study Of ALK Rearrangement In Non-Small Cell Lung Cancer Patients In The Middle East & North AfricaCompletedNCT02304406Results posted
- A Study Evaluating PF-03084014 In Patients With Advanced Breast Cancer With Or Without Notch AlterationsTerminatedNCT02299635Phase 2Results posted
- A Study Of Palbociclib (PD-0332991) + Letrozole VS. Placebo+ Letrozole For 1st Line Treatment Of Asian Postmenopausal Women With ER+/HER2- Advanced Breast Cancer [PALOMA-4]CompletedNCT02297438Phase 3Results posted
- Actual Use Trial of Ibuprofen 400 mgCompletedNCT02294019Phase 3Results posted
- A Phase 1 Study In Japanese Subjects With Type 2 Diabetes Mellitus As MonotherapyCompletedNCT02292433Phase 1Results posted
- The Safety And Efficacy Of Sunitinib In Chinese Patients With Progressive Advanced Or Metastatic Well-Differentiated Unresectable Pancreatic Neuroendocrine TumorsCompletedNCT02282059Results posted
- A Study To Evaluate The Safety And Efficacy Of Tofacitinib Modified Release Tablets Compared To Tofacitinib Immediate Release Tablets In Adult Patients With Rheumatoid ArthritisCompletedNCT02281552Phase 3Results posted
- OPALINE : A Study Of Morbidity And Mortality At 2 YearsCompletedNCT02264665Results posted
- PF-06372865 In Subjects With Chronic Low Back PainCompletedNCT02262754Phase 2Results posted
- Lorazepam for the Treatment of Status Epilepticus or Repetitive Status Epilepticus in JapanCompletedNCT02239380Phase 3Results posted
- Safety And Efficacy Study Of Bosutinib In Patients With Philadelphia Chromosome Positive Chronic Myeloid Leukemia Previously Treated With One Or More Tyrosine Kinase InhibitorsTerminatedNCT02228382Phase 4Results posted
- Single-Agent Glasdegib In Patients With Myelofibrosis Previously Treated With RuxolitinibTerminatedNCT02226172Phase 2Results posted
- Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of PF-06649751 in Parkinson's DiseaseCompletedNCT02224664Phase 1Results posted
- A Study Of PF-06647020 For Adult Patients With Advanced Solid TumorsCompletedNCT02222922Phase 1Results posted
- A Study of PF-06438179 (Infliximab-Pfizer) and Infliximab in Combination With Methotrexate in Subjects With Active Rheumatoid Arthritis (REFLECTIONS B537-02).CompletedNCT02222493Phase 3Results posted
- An Evaluation Of PF-03715455 In Moderate To Severe Uncontrolled AsthmaTerminatedNCT02219048Phase 2Results posted
- A Study To Assess the Effects Of PF-04457845 On BOLD fMRI In Subjects With Post Traumatic Stress DisorderTerminatedNCT02216097Phase 2Results posted
- A Clinical Trial To Evaluate PF-05089771 On Its Own And As An Add-On Therapy To Pregabalin (Lyrica) For The Treatment Of Pain Due To Diabetic Peripheral Neuropathy (DPN)CompletedNCT02215252Phase 2Results posted
- A Study Of PF-05280586 (Rituximab-Pfizer) Or MabThera® (Rituximab-EU) For The First-Line Treatment Of Patients With CD20-Positive, Low Tumor Burden, Follicular Lymphoma (REFLECTIONS B328-06)CompletedNCT02213263Phase 3Results posted
- An Open-Label, Single Dose Pharmacokinetic Study of Benefix (Recombinant Factor IX) in Male Chinese Subjects With Hemophilia BCompletedNCT02213250Phase 1Results posted
- A Phase 1 Single/Multiple Dose Study Of PF-06293620 To Assess Safety, Tolerability And Pharmacokinetics In Subjects With Type 2 Diabetes MellitusCompletedNCT02211261Phase 1Results posted
- Study To Compare Single Dose Of Three Modified Release Formulations Of PF-04937319 With Immediate Release Material-Sparing-Tablet (IR MST) Formulation Previously Studied In Adults With Type 2 Diabetes Mellitus.CompletedNCT02206607Phase 1Results posted
- A Phase 2 Extension Study To Enroll Subjects Who Were Enrolled In B5301001 StudyTerminatedNCT02205476Phase 2Results posted
- Defining Remission With Etanercept in AS in Real Life Clinical PracticeCompletedNCT02202850Results posted
- Study With Etanercept Focusing on Remission and Predictability of Remission in Real Life Clinical PracticeCompletedNCT02202837Results posted
- Evaluation of Ceftaroline Fosamil vs Vancomycin Plus Aztreonam in the Treatment of Patients With Skin Infections.TerminatedNCT02202135Phase 3Results posted